Castellum, Inc. Announces Record Quarterly Revenue
Castellum, Inc. Announces Record Quarterly Revenue Revenue for Q2 2022 was approximately $11 million - Castellum, Inc. (OTC: ONOV) -...
Castellum, Inc. Announces Record Quarterly Revenue Revenue for Q2 2022 was approximately $11 million - Castellum, Inc. (OTC: ONOV) -...
NEWTOWN, Pa., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech...
IRVINE, Calif., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet...
DURHAM, N.C., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable...
ROCKAWAY, N.J., Aug. 05, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that...